Anhui Fengyuan Pharmaceutical Co Ltd (000153.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE0000014X5

Price
5.39 CNY
Market cap
2.51 bn CNY
P/E (2025)
25.20
P/S (2025)
0.65
Dividend yield
1.86 %
Net margin
2.58 %
Return on equity (ROE)
4.72 %
Return on assets (ROA)
1.96 %

Anhui Fengyuan Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue4.28 bn CNY3.86 bn CNY
Gross profit927.30 m CNY708.89 m CNY
Operating income205.09 m CNY186.20 m CNY
EBIT239.97 m CNY160.38 m CNY
Net income160.83 m CNY99.42 m CNY
Diluted EPS – continuing operations0.35 CNY0.21 CNY

Full history since 1997, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Anhui Fengyuan Pharmaceutical Co Ltd

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.